- Home
- CATX vs EOT Comparison
CATX vs EOT Comparison
Compare CATX & EOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- EOT
- Stock Information
- Founded
- CATX 1983
- EOT 2009
- Country
- CATX United States
- EOT United States
- Employees
- CATX N/A
- EOT N/A
- Industry
- CATX Medical/Dental Instruments
- EOT Investment Bankers/Brokers/Service
- Sector
- CATX Health Care
- EOT Finance
- Exchange
- CATX Nasdaq
- EOT Nasdaq
- Market Cap
- CATX 239.0M
- EOT 253.3M
- IPO Year
- CATX N/A
- EOT N/A
- Fundamental
- Price
- CATX $3.44
- EOT $16.07
- Analyst Decision
- CATX Strong Buy
- EOT
- Analyst Count
- CATX 10
- EOT 0
- Target Price
- CATX $13.00
- EOT N/A
- AVG Volume (30 Days)
- CATX 1.5M
- EOT 38.7K
- Earning Date
- CATX 08-11-2025
- EOT 01-01-0001
- Dividend Yield
- CATX N/A
- EOT 4.51%
- EPS Growth
- CATX N/A
- EOT N/A
- EPS
- CATX N/A
- EOT N/A
- Revenue
- CATX $1,471,000.00
- EOT N/A
- Revenue This Year
- CATX N/A
- EOT N/A
- Revenue Next Year
- CATX N/A
- EOT N/A
- P/E Ratio
- CATX N/A
- EOT N/A
- Revenue Growth
- CATX N/A
- EOT N/A
- 52 Week Low
- CATX $1.60
- EOT $14.63
- 52 Week High
- CATX $16.55
- EOT $18.30
- Technical
- Relative Strength Index (RSI)
- CATX 60.53
- EOT 39.08
- Support Level
- CATX $2.96
- EOT $16.07
- Resistance Level
- CATX $3.77
- EOT $16.29
- Average True Range (ATR)
- CATX 0.41
- EOT 0.13
- MACD
- CATX 0.02
- EOT 0.00
- Stochastic Oscillator
- CATX 73.78
- EOT 6.25
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About EOT Eaton Vance Municipal Income Trust EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST
Eaton Vance National Municipal Opportunities Trust is a diversified, closed-end management investment company. The company's investment objective is to provide current income exempt from regular federal income tax and to achieve capital appreciation. It invests a majority of its assets in debt obligations issued by or on behalf of states, territories, and possessions of the United States, including the District of Columbia, and their political subdivisions, agencies, or instrumentalities, the interest on which is exempt from regular federal income tax.